NAVENZY
Cycle Pharmaceuticals Ltd.
Application Filed: 2021-07-29
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90855592 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Mary Frances Love |
| Attorney Docket Number | 14218.131 |
Timeline
| 2021-07-29 | Application Filed |
| 2021-08-02 | Location: NEW APPLICATION PROCESSING |
| 2021-08-02 | Status: Live/Pending |
| 2021-08-02 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cycle Pharmaceuticals Ltd. |
| Entity Statement | private limited company |
| Address | Bailey Grundy Barrett Building Little St Mary's Lane Cambridge GB CB21RR |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 16 |
| U.S. Codes: | 002,005,022,023,029,037,038,050 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 39 |
| U.S. Codes: | 100,105 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical agents for the treatment of rare genetic diseases; pharmaceutical agents for the treatment of disorders of the circulatory system; pharmaceutical agents for the treatment of blood diseases and disorders; pharmaceutical agents for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods; pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of disorders of the circulatory system; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of disorders of the circulatory system; pharmaceuticals for the treatment of blood diseases and disorders; pharmaceuticals for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for the treatment of disorders of the circulatory system; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the circulatory system; supplements for the treatment of rare genetic diseases; supplements for the treatment of disorders of the circulatory system; supplements for the treatment of blood diseases and disorders; supplements for the treatment of blood diseases and disorders, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; supplements for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of rare genetic diseases; biological preparations for the treatment of disorders of the circulatory system; biological preparations for the treatment of blood diseases and disorders; biological preparations for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of rare genetic diseases; chemical preparations for the treatment of disorders of the circulatory system chemical preparations for the treatment of blood diseases and disorders; chemical preparations for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents for use in pharmaceuticals; drug delivery agents for use in the treatment of rare genetic diseases; drug delivery agents for use in the treatment of disorders of the circulatory system; drug delivery agents for use in the treatment of blood diseases and disorders; drug delivery agents for the treatment of phenylketonuria (PKU); drugs and medicines for the treatment of rare genetic diseases; drugs and medicines for the treatment of disorders of the circulatory system; drugs and medicines for the treatment of blood diseases and disorders; drugs and medicines for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes; enzyme preparations for the treatment of rare genetic diseases; enzyme preparations for the treatment of disorders of the circulatory system; enzyme preparations for the treatment of blood diseases and disorders; enzyme preparations for the treatment of phenylketonuria (PKU); medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of rare genetic diseases; medical preparations for the treatment of disorders of the circulatory system; medical preparations for the treatment of blood diseases and disorders; medical preparations for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of rare genetic diseases; medicines for the treatment of disorders of the circulatory system; medicines for the treatment of blood diseases and disorders; medicines for the treatment of phenylketonuria (PKU), all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches. parts and fittings for all of the aforesaid goods |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2021-08-02 | 1 NWAP I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-08-05 | 2 COAR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-08-05 | 3 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-08-05 | 4 CHAN I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-09-27 | 5 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-12-17 | 6 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-12-30 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-12-30 | 8 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-12-30 | 9 GNRN O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-07-18 | 10 DOCK D:Assigned to Examiner |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2022-07-18 | 11 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2022-07-18 | 12 MAB2 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 